EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
1. 系统已在2025-07-22 15:47:10对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.ccell.2024.11.006
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1535610824004410
其他信息:
出版社: Elsevier BV
作者: Yusuke Isshiki; Xi Chen; Matt Teater; Ioannis Karagiannidis; Henna Nam; Winson Cai; Cem Meydan; Min Xia; Hao Shen; Johana Gutierrez; Vigneshwari Easwar Kumar; Sebastián E. Carrasco; Madhu M. Ouseph; Samuel Yamshon; Peter Martin; Ofir Griess; Efrat Shema; Patrizia Porazzi; Marco Ruella; Renier J. Brentjens; Giorgio Inghirami; Roberta Zappasodi; Amy Chadburn; Ari M. Melnick; Wendy Béguelin